| 507 | 7 | 115 |
| 下载次数 | 被引频次 | 阅读次数 |
脓毒症急性肺损伤发病机制复杂、死亡率高，目前尚缺乏有针对性的治疗手段。肠道菌群紊乱可通过“肠-肺轴”参与急性肺损伤发生发展。通过肠道菌群这一现代医学认识来阐释中医学“肺合大肠”理论，基于“肺合大肠”探讨肠道菌群紊乱在急性肺损伤中医发病机制中的作用，以“肺肠同治”为基本原则，提出以改善肠道生态平衡为核心的急性肺损伤防治新策略，明确分期论治：初期邪在卫表，肺气郁闭，肠络受损，治疗以清热宣肺、润下通腑为主，佐以理气机、消痈滞；中期邪炽气营，肺络瘀阻，肠腑失通，治疗以解毒清肺、攻下通腑兼以凉血化瘀；后期血分热极，肺阴亏耗，津枯肠结，逆证丛生，治以养阴透热、通腑开闭佐以扶正救逆。
Abstract：The pathogenesis of acute lung injury caused by sepsis is complex,and the mortality rate is high,and there is currently a lack of targeted treatment methods. Intestinal flora disorders,which can participate in the occurrence and development of acute lung injury through the “ intestine-lung axis ”. The paper interprets the basic theory of “lung being connected with large intestine” in traditional Chinese medicine through the modern medical understanding of intestinal flora,discusses the role of intestinal flora disturbance in the pathogenesis of acute lung injury in traditional Chinese medicine,takes “lung and intestine co-treatment” as the fundamental principle,proposes a new prevention and treatment strategy for acute lung injury with the improvement of intestinal ecological balance as the core,and clearly defines the stage treatment. In the early stage,the pathogenic factors are on the surface of the body,there are lung qi stagnation and intestinal collateral damage. The treatment mainly focuses on clearing heat,promoting lung function,moistening the lower-jiao and clearing fu-viscera,and promoting qi circulation,as well as eliminating carbuncle stagnation. In the middle stage,the pathogenic factors are intense and the intestines and organs are obstructed. The treatment is to detoxify and clear the lungs,drege the lower-jiao and clear fu-viscera,and cool blood and dissipate blood stasis. In the late stage,the blood is in extreme heat,the fluid dries up and the lung yin is depleted,the intestines stagnation is formed,and the syndrome of inversion is clustered. The treatment is to nourish yin and clear heat,open the fu-viscera,which is assisted by supporting the healthy qi and reversing qi.
[1] MEYER N J,GATTINONI L,CALFEE C S. Acute respiratory distress syndrome[J]. Lancet,2021,398(10300):622-637.
[2] AURIEMMA C L,ZHUO H,DELUCCHI K,et al. Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis[J]. Intensive Care Med,2020,46(6):1222-1231.
[3] ADAK A,KHAN M R. An insight into gut microbiota and its functionalities[J]. Cell Mol Life Sci,2019,76(3):473-493.
[4] DEITCH E A. Bacterial translocation or lymphatic drainage of toxic products from the gut:what is important in human beings?[J]. Surgery,2002,131(3):241-244.
[5]王宪正，赵霞，狄留庆，等.“肺与大肠相表里”的研究进展[J].世界科学技术-中医药现代化，2020,22(3):850-855.
[6]李磊，孙广仁，张庆祥，等.“气机升降”在“肺合大肠”关系中的生理意义[J].山东中医杂志，2013,32(10):699-700,710.
[7] TANG J,XU L,ZENG Y,et al. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-κB signaling pathway[J]. Int Immunopharmacol,2021,91:107272.
[8] LOU X,XUE J,SHAO R,et al. Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances[J]. Front Immunol,2022,13:1063543.
[9]李盼飞，卢曦，王艳，等.中医对现代医学肠道功能的认识[J].环球中医药，2019,12(6):871-874.
[10] ZHOU X,LIAO Y. Gut-lung crosstalk in sepsisinduced acute lung injury[J]. Front Microbiol,2021,12:779620.
[11] JIN C,CHEN J,GU J,et al. Gut-lymph-lung pathway mediates sepsis-induced acute lung injury[J]. Chin Med J,2020,133(18):2212-2218.
[12] VANAJA S K,RUSSO A J,BEHL B,et al. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation[J]. Cell,2016,165(5):1106-1119.
[13] NATH S,KITSIOS G D,BOS L D J. Gut-lung crosstalk during critical illness[J]. Curr Opin Crit Care,2023,29(2):130-137.
[14]韩丽丽，刘银辉，赵利慧，等.肠道菌群紊乱对Treg细胞影响的研究进展[J].中国微生态学杂志，2017,29(1):101-105.
[15] CHIOMA O S,MALLOTT E K,CHAPMAN A,et al.Gut microbiota modulates lung fibrosis severity following acute lung injury in mice[J]. Commun Biol,2022,5(1):1401.
[16] FAY K T,KLINGENSMITH N J,CHEN C W,et al.The gut microbiome alters immunophenotype and survival from sepsis[J]. FASEB J,2019,33(10):11258-11269.
[17] WILMORE J R,GAUDETTE B T,GOMEZ ATRIA D,et al. Commensal microbes induce serum IgA responses that protect against polymicrobial sepsis[J].Cell Host&Microbe,2018,23(3):302-311.e3.
[18] CHENG H,GUAN X,CHEN D,et al. The Th17/treg cell balance:a gut microbiota-modulated story[J]. Microorganisms,2019,7(12):E583.
[19] GAUGUET S,D’ORTONA S,AHNGER-PIER K,et al.Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia[J]. Infect Immun,2015,83(10):4003-4014.
[20] SCHULTHESS J,PANDEY S,CAPITANI M,et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages[J]. Immunity,2019,50(2):432-445.e7.
[21] LI B,YIN G F,WANG Y L,et al. Impact of fecal microbiota transplantation on TGF-β1/Smads/ERK signaling pathway of endotoxic acute lung injury in rats[J].3 Biotech,2020,10(2):52.
[22]胡英山，王晶晶，高红梅.脓毒症相关肠道功能障碍发病机制的研究进展[J].天津医药，2023,51(3):333-336.
[23] OKUMURA R,TAKEDA K. Roles of intestinal epithelial cells in the maintenance of gut homeostasis[J].Exp Mol Med,2017,49(5):e338.
[24] MATHEWSON N D,JENQ R,MATHEW A V,et al.Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease[J]. Nat Immuno,2016,17(5):505-513.
[25] LARABI A,BARNICH N,NGUYEN H T T. New insights into the interplay between autophagy,gut microbiota and inflammatory responses in IBD[J]. Autophagy,2020,16(1):38-51.
[26] XI S,WANG Y,WU C,et al. Intestinal epithelial cell exosome launches IL-1β-mediated neuron injury in sepsis-associated encephalopathy[J]. Front Cell Infect Microbiol,2021,11:783049.
[27] ANDERSON C J,MEDINA C B,BARRON B J,et al.Microbes exploit death-induced nutrient release by gut epithelial cells[J]. Nature,2021,596:262-267.
[28] CHENG K T,XIONG S,YE Z,et al. Caspase-11-mediated endothelial pyroptosis underlies endotoxemiainduced lung injury[J]. J Clin Invest,2017,127(11):4124-4135.
[29] WANG Y H,YAN Z Z,LUO S D,et al. Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischaemia/reperfusion in mice[J].Eur Respir J,2023,61(2):2200840.
[30] DENG F,ZHAO B C,YANG X,et al. The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis[J]. Gut Microbes,2021,13(1):1-21.
[31] TAN J,MCKENZIE C,POTAMITIS M,et al. The role of short-chain fatty acids in health and disease[J].Adv Immunol,2014,121:91-119.
[32] LI N,LIU X X,HONG M,et al. Sodium butyrate alleviates LPS-induced acute lung injury in mice via inhibiting HMGB1 release[J]. Int Immunopharmacol,2018,56:242-248.
[33] CHOU R H,WU P S,WANG S C,et al. Paradox of trimethylamine-N-oxide,the impact of malnutrition on microbiota-derived metabolites and septic patients[J].J Intensive Care,2021,9(1):65.
[34] HAAK B W,WIERSINGA W J. The role of the gut microbiota in sepsis[J]. Lancet Gastroenterol Hepatol,2017,2(2):135-143.
[35] VINCENT J L,RELLO J,MARSHALL J,et al. International study of the prevalence and outcomes of infection in intensive care units[J]. JAMA,2009,302(21):2323-2329.
[36] GüNTHER A,SIEBERT C,SCHMIDT R,et al. Surfactant alterations in severe pneumonia,acute respiratory distress syndrome,and cardiogenic lung edema[J]. Am J Respir Crit Care Med,1996,153(1):176-184.
[37] NAKAGAWA N K,FRANCHINI M L,DRIUSSO P,et al. Mucociliary clearance is impaired in acutely ill patients[J]. Chest,2005,128(4):2772-2777.
[38]刘畅，刘雄伟，李嘉欣，等.基于16S rRNA基因测序研究金银花和山银花对急性肺损伤大鼠肠道菌群的影响[J].中国微生态学杂志，2021,33(2):130-137.
[39]武振帅，徐誉彰，李宏雅，等.基于高通量测序研究黄芩-连翘配伍对LPS诱导的急性肺炎小鼠肠道菌群的影响[J].动物医学进展，2023,44(5):50-56.
[40]运苛政，王玉玉，刘颖，等.清肠理气汤保留灌肠对急性胰腺炎患者氧化应激及肠道菌群的影响[J].中医药临床杂志，2021,33(11):2195-2198.
[41]陈曦，李志军.清瘟败毒联合大承气汤治疗肺炎合并脓毒症的临床疗效分析[J].海峡药学，2018,30(5):126-127.
[42]马丽琼，段金旗，于明克.大黄对脓毒症大鼠胃肠道菌群的影响[J].中华临床医师杂志（电子版），2012,6(10):2790-2792.
[43]陈华海，赵昌会，朱家良，等.银杏双黄酮和银杏内酯B与人体肠道菌群体外互作研究[J].微生物学报，2021,61(8):2413-2426.
[44]汪磊，刘阳，李慧，等.中医药调节肠道菌群治疗脓毒症研究进展[J].中国中医急症，2021,30(5):924-927.
[45]周洁，毕建朋.犀角地黄汤加味通过NF-κB信号通路对败血症导致的炎症和肺损伤的影响[J].中草药，2019,50(6):1395-1399.
[46]黄港，晏娟，邹佳华，等.观察犀角地黄汤对血热型银屑病的影响[J].江西中医药，2022,53(5):36-39.
[47]黄元庆，周明亮，周皓岚.参附汤合生脉散治疗脓毒症休克阴竭阳脱证[J].长春中医药大学学报，2022,38(10):1117-1121.
[48]包春秀，姜永红.宣白承气汤治疗肺系疾病研究进展[J].山东中医药大学学报，2021,7(2):280-284.
[49]曹占鸿，潘建衡，李娜，等.生脉散现代药理作用及作用机制的研究进展[J].中国实验方剂学杂志，2019,25(22):212-218.
[50]丁奇，冯斯文，许功灏，等.人参茎叶总皂苷对急性肺损伤小鼠肠道菌群和短链脂肪酸代谢的影响[J].中国中药杂志，2023,48(5):1319-1329.
[51] HAN S,ZHENG H,HAN F,et al. Lactobacillus johnsonii 6084 alleviated sepsis-induced organ injury by modulating gut microbiota[J]. Food Sci Nutr,2022,10(11):3931-3941.
[52] KIM S M,DEFAZIO J R,HYOJU S K,et al. Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity[J]. Nat Commun,2020,11(1):2354.
[53] WAN Y,WANG S,NIU Y,et al. Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis[J]. Front Cell Infect Microbiol,2023,13:1139436.
基本信息:
DOI：10.16295/j.cnki.0257-358x.2024.12.006
中图分类号:R278
引用信息:
[1]许一飞,靳敏燕,黄迪,等.从“肺合大肠”探讨肠道菌群紊乱与脓毒症急性肺损伤的相关性[J].山东中医杂志,2024,43(12):1342-1348+1386.DOI:10.16295/j.cnki.0257-358x.2024.12.006.
基金信息:
国家自然科学基金项目（编号：82274320）; 山东省自然科学基金项目（编号：ZR2020MH392）; 山东省自然科学联合基金项目（编号：ZR2021LZY027）
2024-12-05
2024-12-05